Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Cash and Equivalents of $791.30 million for fiscal year 2025.
WEST PHARMACEUTICAL SERVICES INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $791.30M | +63.3% |
| 2024 | $484.60M | -43.2% |
| 2023 | $853.90M | -4.5% |
| 2022 | $894.30M | +17.3% |
| 2021 | $762.60M | +23.9% |
| 2020 | $615.50M | +40.2% |
| 2019 | $439.10M | +30.1% |
| 2018 | $337.40M | +43.0% |
| 2017 | $235.90M | +16.2% |
| 2016 | $203.00M | -26.1% |
| 2015 | $274.60M | +7.6% |
| 2014 | $255.30M | +11.0% |
| 2013 | $230.00M | +42.1% |
| 2012 | $161.90M | +76.4% |
| 2011 | $91.80M | -43.3% |
| 2011 | $161.90M | +46.9% |
| 2010 | $110.20M | +32.6% |
| 2009 | $83.10M | -4.7% |
| 2008 | $87.20M | -19.6% |
| 2007 | $108.40M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $628.50M | +28.0% | +23.3% |
| June 30, 2025 | $509.70M | +14.2% | +26.1% |
| March 31, 2025 | $404.20M | -32.8% | -16.6% |
| December 31, 2024 | $484.60M | -43.2% | -1.3% |
| September 30, 2024 | $490.90M | -45.4% | +10.0% |
| June 30, 2024 | $446.20M | -44.0% | -25.9% |
| March 31, 2024 | $601.80M | -32.1% | -29.5% |
| December 31, 2023 | $853.90M | -4.5% | -5.0% |
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +63.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, WEST PHARMACEUTICAL SERVICES INC’s cash and equivalents has grown by 630.0% (from $108.40 million to $791.30 million).
- The most recent figure is from WEST PHARMACEUTICAL SERVICES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: